sorrento therapeutics inc
(SRNE:Consolidated Issue listed on NASDAQ Capital Market)
Kim D. Janda Ph.D.
Director and Member of Corporate Governance/Nominating Committee, Sorrento Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 19 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Dr. Kim D. Janda, Ph.D. has been the Ely R. Callaway, Jr. Chaired Professor in the Departments of Chemistry, Immunology and Microbial Science at The Scripps Research Institute (TSRI) since 1996. Dr. Janda has been the Director of the Worm Institute of Research and Medicine (WIRM) at The Scripps Research Institute since 2005. He has served as a Associate Professor/Skaggs Scholar within the Skaggs Institute of Chemical Biology, also at The Scripps Research Institute, since ...
6042 Cornerstone Ct. WestPhone: 858-210-3700
San Diego, California 92121
Board Members Memberships*
Director and Member of Corporate Governance/Nominating Committee
University of South Florida
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|There is no Competitor Compensation data available.|